Chemed logo

ChemedNYSE: CHE

Profile

Sector:

Healthcare

Country:

United States

IPO:

03 May 1973

Next earnings report:

26 July 2024

Last dividends:

30 May 2024

Next dividends:

N/A
$8.15 B
-17%vs. 3y high
92%vs. sector
-23%vs. 3y high
50%vs. sector
-45%vs. 3y high
90%vs. sector
-18%vs. 3y high
53%vs. sector

Price

after hours | Wed, 03 Jul 2024 20:20:00 GMT
$540.00+$0.55(+0.10%)
$589.23 M$599.19 M
$589.23 M$65.02 M

Analysts recommendations

Institutional Ownership

CHE Latest News

Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25
businesswire.com01 July 2024 Sentiment: -

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, July 25, 2024, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through th.

Chemed Corporation to Present at the Jefferies 2024 Global Healthcare Conference
businesswire.com29 May 2024 Sentiment: POSITIVE

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024, at approximately 9:00 a.m. (ET) at the New York Marriott Marquis in New York City. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the.

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
businesswire.com20 May 2024 Sentiment: POSITIVE

CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2024 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2024. Stockholders also approved Chemed's executive compensation. In addition, stockholders voted against the stockholder proposal on ratification of termination pay. Dividend Declared Following the stockholders' meeting.

Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
Zacks Investment Research25 April 2024 Sentiment: POSITIVE

Chemed's (CHE) Q1 2024 earnings show strong revenue growth and higher average revenues per patient per day for VITAS.

Chemed (CHE) Q1 Earnings Miss Estimates
Zacks Investment Research24 April 2024 Sentiment: NEGATIVE

Chemed (CHE) reported quarterly earnings of $5.20 per share, falling short of the Zacks Consensus Estimate of $5.47 per share. This is higher than the earnings of $4.82 per share from the previous year.

Here's Why You Should Retain Chemed (CHE) Stock for Now
Zacks Investment Research17 April 2024 Sentiment: POSITIVE

Investors are feeling positive about Chemed (CHE) due to the strong performance of the VITAS Healthcare and Roto-Rooter segments.

Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care
Zacks Investment Research14 March 2024 Sentiment: POSITIVE

Chemed's (CHE) VITAS segment is set to acquire the hospice assets of Covenant Care in Florida and Alabama.

Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
Business Wire08 March 2024 Sentiment: POSITIVE

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 34th Annual Healthcare Conference on Tuesday, March 12, 2024, at approximately 12:00 p.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be ac.

Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think "Yes"
Zacks Investment Research04 March 2024 Sentiment: POSITIVE

Chemed (CHE) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Chemed (CHE) Q4 Earnings Surpass Estimates, Margins Expand
Zacks Investment Research29 February 2024 Sentiment: POSITIVE

Chemed's (CHE) fourth-quarter 2023 performance reflects an improvement in VITAS' operational metrics.

  • 1(current)
  • 2
  • 3

What type of business is Chemed?

Chemed Corporation is an American company that provides medical and service services. Founded in 1947, the headquarters is located in Cincinnati, Ohio. Chemed Corporation has two subsidiaries: Vitas Healthcare Corporation (VITAS) and Roto-Rooter. VITAS offers hospice and palliative care services to patients across the United States, provided through a network of doctors, nurses, home care aides, social workers, and volunteers. Vitas Healthcare Corporation has approximately 8 hospice programs in 14 states and the District of Columbia. Roto-Rooter provides plumbing, sewer, and drain repair services, as well as water and sewer line cleaning services, and water damage restoration services throughout the United States and Canada.

What sector is Chemed in?

Chemed is in the Healthcare sector

What industry is Chemed in?

Chemed is in the Medical Care Facilities industry

What country is Chemed from?

Chemed is headquartered in United States

When did Chemed go public?

Chemed initial public offering (IPO) was on 03 May 1973

What is Chemed website?

https://www.chemed.com

Is Chemed in the S&P 500?

No, Chemed is not included in the S&P 500 index

Is Chemed in the NASDAQ 100?

No, Chemed is not included in the NASDAQ 100 index

Is Chemed in the Dow Jones?

No, Chemed is not included in the Dow Jones index

When does Chemed report earnings?

The next expected earnings date for Chemed is 26 July 2024